Health ❯ Nutrition ❯ Weight Loss

Pharmaceuticals

GLP-1 Drugs GLP-1 Receptor Agonists Semaglutide Drug Development Obesity Treatments Clinical Trials Mounjaro Orforglipron Diet Drugs Drug Mechanisms Prescription Medications GLP-1 Agonists Energy Expenditure Diabetes Medications Drug Combination Therapy Monoclonal Antibodies GLP Inhibitors GLP-1 Obesity Treatment Weight Loss Drugs Retatrutide Appetite Suppressants Liraglutide and Semaglutide

Berkeley Compound TOFA Cuts Fat in Obese Mice by Raising Energy Use

By increasing whole‑body energy expenditure, TOFA produced large fat loss in mice and could complement appetite‑reducing GLP‑1 drugs.

TOFA Boosts Fat Burning in Mice While Preserving Muscle

Experimental Antibody Preserves Muscle During Tirzepatide Weight Loss

Oral GLP-1 Weight-Loss Pills Curb Hedonic Eating by Hitting Deep-Brain Circuit in Mice

Andy Cohen Says He Micro-Dosed a GLP-1 This Summer, Losing 25 Pounds

Serena Williams’ GLP-1 Endorsement Triggers Backlash and Conflict-of-Interest Questions

Tufts Chemists Unveil Four-Receptor Obesity Drug to Challenge Bariatric Surgery